Skip to main content

Woolson Daniel

In the past year, 3 open-market sale filings worth $1.70M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$1.70M
3 filings
Net
−$1.70M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Woolson Daniel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 13, 2026 (view filing)6:56 PM ETAug 13Same dayWoolson DanielVP, GM-Infusion CapitalSSale−5.42K$181.33−$982.3K−24.1%17.1K after
May 22, 2026 (view filing)May 22Same dayWoolson DanielPresidentSSale−2.12K$132.21−$280.7K−8.6%22.5K after
Nov 25, 2025 (view filing)Nov 25Same dayWoolson DanielVP, GM-Infusion CapitalSSale−2.90K$152.35−$441.4K−20.4%11.3K after
Dec 6, 2024 (view filing)Dec 6Same dayWoolson DanielVP, GM-Infusion CapitalSSale−2.24K$156.25−$350.2K−17.1%10.9K after
Aug 30, 2024 (view filing)Aug 30Same dayWoolson DanielVP, GM-Infusion CapitalSSale−2.50K$163.22−$408.4K−16.0%13.1K after
Mar 15, 2024 (view filing)Mar 15Same dayWoolson DanielVP, GM-Infusion CapitalSSale−791$98.27−$77.7K−5.4%14.0K after
Dec 1, 2023 (view filing)Dec 1Same dayWoolson DanielVP, GM-Infusion CapitalSSale−1.73K$88.03−$152.2K−14.9%9.88K after
Feb 2, 2023 (view filing)Feb 2Same dayWoolson DanielVP, GM-Infusion CapitalSSale−1.73K$200.00−$346.2K−15.9%9.15K after